|
1
|
Nouri A, Gondar R, Schaller K and Meling
T: Chronic subdural hematoma (cSDH): A review of the current state
of the art. Brain Spine. 1(100300)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhong D, Cheng H, Xian Z, Ren Y, Li H, Ou
X and Liu P: Advances in pathogenic mechanisms, diagnostic methods,
surgical and non-surgical treatment, and potential recurrence
factors of Chronic Subdural Hematoma: A review. Clin Neurol
Neurosurg. 242(108323)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Feghali J, Yang W and Huang J: Updates in
chronic subdural hematoma: Epidemiology, etiology, pathogenesis,
treatment, and outcome. World Neurosurg. 141:339–345.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu T, Zhao Z, Liu M, An S, Nie M, Liu X,
Qian Y, Tian Y, Zhang J and Jiang R: The pharmacological landscape
of chronic subdural hematoma: A systematic review and network
meta-analysis of randomized and non-randomized controlled studies.
Burns Trauma. 12(tkae034)2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Verma Y, Abdelghaffar M, Verma O, Gajjar
A, Ghozy S and Kallmes DF: Bevacizumab: The future of chronic
subdural hematoma. Interv Neuroradiol: November 21, 2024 (Epub
ahead of print).
|
|
6
|
Morofuji Y, Nakagawa S, Ujifuku K,
Fujimoto T, Otsuka K, Niwa M and Tsutsumi K: Beyond lipid-lowering:
Effects of statins on cardiovascular and cerebrovascular diseases
and cancer. Pharmaceuticals (Basel). 15(151)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Araujo FA, Rocha MA, Mendes JB and Andrade
SP: Atorvastatin inhibits inflammatory angiogenesis in mice through
down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed
Pharmacother. 64:29–34. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim SK, Choe JY, Kim JW, Park KY and Kim
B: Anti-Inflammatory effect of atorvastatin and rosuvastatin on
monosodium urate-induced inflammation through IL-37/Smad3-complex
activation in an in vitro study using THP-1 macrophages.
Pharmaceuticals (Basel). 17(883)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chan DY, Chan DT, Sun TF, Ng SC, Wong GK
and Poon WS: The use of atorvastatin for chronic subdural
haematoma: A retrospective cohort comparison study. Br J Neurosurg.
31:72–77. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jiang R, Zhao S, Wang R, Feng H, Zhang J,
Li X, Mao Y, Yuan X, Fei Z, Zhao Y, et al: Safety and efficacy of
atorvastatin for chronic subdural hematoma in chinese patients: A
randomized ClinicalTrial. JAMA Neurol. 75:1338–1346.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Monteiro GA, Queiroz TS, Goncalves OR,
Cavalcante-Neto JF, Batista S, Rabelo NN, Welling LC, Figueiredo
EG, Leal PRL and Solla DJF: Efficacy and safety of atorvastatin for
chronic subdural hematoma: An updated systematic review and
meta-analysis. World Neurosurg. 188:177–184. 2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Quan W, Zhang Z, Li P, Tian Q, Huang J,
Qian Y, Gao C, Su W, Wang Z, Zhang J, et al: Role of regulatory T
cells in atorvastatin induced absorption of chronic subdural
hematoma in rats. Aging Dis. 10:992–1002. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang L, Li N, Yang L, Wang D, Qiang S and
Zhao Z: Atorvastatin-induced absorption of chronic subdural
hematoma is partially attributed to the polarization of
macrophages. J Mol Neurosci. 72:565–573. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liang C, Zhang B, Li R, Guo S and Fan X:
Network pharmacology -based study on the mechanism of traditional
Chinese medicine in the treatment of glioblastoma multiforme. BMC
Complement Med Ther. 23(342)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Carlson M: Genome wide annotation for
Human. Bioconductor, 2022. https://bioconductor.org/packages/org.Hs.eg.db.
|
|
16
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yu G: enrichplot: Visualization of
Functional Enrichment Result. Bioconductor, 2022. https://bioconductor.org/packages/enrichplot.
|
|
18
|
Luo W and Brouwer C: Pathview: An
R/Bioconductor package for pathway-based data integration and
visualization. Bioinformatics. 29:1830–1831. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wickham H: ggplot2: Elegant Graphics for
Data Analysis. 1st Edition. Springer, New York, NY, 2009.
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bao XM, Wu CF and Lu GP: Atorvastatin
attenuates homocysteine-induced apoptosis in human umbilical vein
endothelial cells via inhibiting NADPH oxidase-related oxidative
stress-triggered p38MAPK signaling. Acta Pharmacol Sin.
30:1392–1398. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li D, Chen H, Romeo F, Sawamura T, Saldeen
T and Mehta JL: Statins modulate oxidized low-density
lipoprotein-mediated adhesion molecule expression in human coronary
artery endothelial cells: Role of LOX-1. J Pharmacol Exp Ther.
302:601–605. 2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liang C, Wei T, Zhang T and Niu C:
Adipose-derived stem cell-mediated alphastatin targeting delivery
system inhibits angiogenesis and tumor growth in glioma. Mol Med
Rep. 28(215)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shityakov S and Förster C: In silico
predictive model to determine vector-mediated transport properties
for the blood-brain barrier choline transporter. Adv Appl Bioinform
Chem. 7:23–36. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hsin KY, Ghosh S and Kitano H: Combining
machine learning systems and multiple docking simulation packages
to improve docking prediction reliability for network pharmacology.
PLoS One. 8(e83922)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xiong L, Chen Q and Liu H: Network
pharmacology and molecular docking identified IL-6 as a critical
target of Qing Yan He Ji against COVID-19. Medicine (Baltimore).
103(e40720)2024.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ahmad A, Sayed A, Ginnebaugh KR, Sharma V,
Suri A, Saraph A, Padhye S and Sarkar FH: Molecular docking and
inhibition of matrix metalloproteinase-2 by novel
difluorinatedbenzylidene curcumin analog. Am J Transl Res.
7:298–308. 2015.PubMed/NCBI
|
|
29
|
Kumar NK, Geervani VS, Kumar RSM, Singh S,
Abhishek M and Manimozhi M: Data-driven dentistry: Computational
revelations redefining pulp capping. J Conserv Dent Endod.
27:649–653. 2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dos Santos RV, Barrionuevo MVF, Vieira
MRF, Mazoni I and Tasic L: Plasminogen activator inhibitors in
thrombosis: Structural analysis and potential natural inhibitors.
ACS Omega. 10:27348–27362. 2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Madej M, Halama A, Chrobak E and Gola JM:
Time-dependent impact of betulin and its derivatives on IL-8
expression in colorectal cancer cells with molecular docking
studies. Int J Mol Sci. 26(6186)2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Weigel R, Schilling L and Krauss JK: The
pathophysiology of chronic subdural hematoma revisited: Emphasis on
aging processes as key factor. Geroscience. 44:1353–1371.
2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jensen TSR, Olsen MH, Lelkaitis G, Kjaer
A, Binderup T and Fugleholm K: Urokinase plasminogen activator
receptor: An important focal player in chronic subdural hematoma?
Inflammation. 47:1015–1027. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tamura R, Sato M, Yoshida K and Toda M:
History and current progress of chronic subdural hematoma. J Neurol
Sci. 429(118066)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Katano H, Kamiya K, Mase M, Tanikawa M and
Yamada K: Tissue plasminogen activator in chronic subdural
hematomas as a predictor of recurrence. J Neurosurg. 104:79–84.
2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shi Z, Yao C, Shui Y, Li S and Yan H:
Research progress on the mechanism of angiogenesis in wound repair
and regeneration. Front Physiol. 14(1284981)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Costantini TW, Kornblith LZ, Pritts T and
Coimbra R: The intersection of coagulation activation and
inflammation after injury: What you need to know. J Trauma Acute
Care Surg. 96:347–356. 2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cambier S, Gouwy M and Proost P: The
chemokines CXCL8 and CXCL12: molecular and functional properties,
role in disease and efforts towards pharmacological intervention.
Cell Mol Immunol. 20:217–251. 2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Adumitrachioaiei H, Sasaran MO and
Marginean CO: The diagnostic and prognostic role of interleukin 6
and interleukin 8 in childhood acute gastroenteritis-a review of
the literature. Int J Mol Sci. 25(7655)2024.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Schumertl T, Lokau J, Rose-John S and
Garbers C: Function and proteolytic generation of the soluble
interleukin-6 receptor in health and disease. Biochim Biophys Acta
Mol Cell Res. 1869(119143)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Matsushima K, Yang D and Oppenheim JJ:
Interleukin-8: An evolving chemokine. Cytokine.
153(155828)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hong HJ, Kim YJ, Yi HJ, Ko Y, Oh SJ and
Kim JM: Role of angiogenic growth factors and inflammatory cytokine
on recurrence of chronic subdural hematoma. Surg Neurol.
71:161–165; discussion 165-166. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mustafa S, Koran S and AlOmair L: Insights
into the role of matrix metalloproteinases in cancer and its
various therapeutic aspects: A review. Front Mol Biosci.
9(896099)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Muneer PMA, Pfister BJ, Haorah J and
Chandra N: Role of matrix metalloproteinases in the pathogenesis of
traumatic brain injury. Mol Neurobiol. 53:6106–6123.
2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hua C, Zhao G, Feng Y, Yuan H, Song H and
Bie L: Role of matrix metalloproteinase-2, matrix
metalloproteinase-9, and vascular endothelial growth factor in the
development of chronic subdural hematoma. J Neurotrauma. 33:65–70.
2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kwak SY, Park S, Kim H, Lee SJ, Jang WS,
Kim MJ, Lee S, Jang WI, Kim AR, Kim EH, et al: Atorvastatin
inhibits endothelial PAI-1-mediated monocyte migration and
alleviates radiation-induced enteropathy. Int J Mol Sci.
22(1828)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hou X and Pei F: Estradiol inhibits
cytokine-induced expression of VCAM-1 and ICAM-1 in cultured human
endothelial cells via AMPK/PPARalpha activation. Cell Biochem
Biophys. 72:709–717. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
O YM, Tsang SL and Leung GK:
Fibrinolytic-facilitated chronic subdural hematoma drainage-A
systematic review. World Neurosurg. 150:e408–e419. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wang D, Li T, Wei H, Wang Y, Yang G, Tian
Y, Zhao Z, Wang L, Yu S, Zhang Y, et al: Atorvastatin enhances
angiogenesis to reduce subdural hematoma in a rat model. J Neurol
Sci. 362:91–99. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chen M, Da L, Zhang Q, Liu J, Tang J and
Zha Z: Development of a predictive model for assessing the risk
factors associated with recurrence following surgical treatment of
chronic subdural hematoma. Front Surg. 11(1429128)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jensen TSR, Thiesson EM, Fugleholm K,
Wohlfahrt J and Munch TN: Inflammatory risk factors for chronic
subdural hematoma in a nationwide cohort. J Inflamm Res.
17:8261–8270. 2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hori YS, Aoi M, Oda K and Fukuhara T:
Presence of a malignant tumor as a novel predictive factor for
repeated recurrences of chronic subdural hematoma. World Neurosurg.
105:714–719. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Dubinski D, Won SY, Trnovec S, Gounko K,
Baumgarten P, Warnke P, Cantre D, Behmanesh B, Bernstock JD,
Freiman TM, et al: Recurrence of chronic subdural hematoma due to
low-grade infection. Front Neurol. 13(1012255)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hermida N and Balligand JL: Low-density
lipoprotein-cholesterol-induced endothelial dysfunction and
oxidative stress: The role of statins. Antioxid Redox Signal.
20:1216–1237. 2014.PubMed/NCBI View Article : Google Scholar
|
